These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30799425)

  • 1. Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
    Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
    Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.
    Javed Z; Ahmed Shah F; Rajabi S; Raza Q; Iqbal Z; Ullah M; Ahmad T; Salehi B; Sharifi-Rad M; Pezzani R; Yaqoob F; Sadia H; Iriti M; Sharifi-Rad J; Cho WC
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):281-287. PubMed ID: 32102500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
    Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
    Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
    Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
    Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma.
    Zhang R; Hardin H; Huang W; Buehler D; Lloyd RV
    Endocr Pathol; 2018 Mar; 29(1):1-8. PubMed ID: 29280051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of long non-coding RNAs in the pathogenesis of thyroid cancer.
    Ghafouri-Fard S; Mohammad-Rahimi H; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104332. PubMed ID: 31706987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
    Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
    Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
    Murugan AK; Munirajan AK; Alzahrani AS
    Endocr Relat Cancer; 2018 Feb; 25(2):R59-R82. PubMed ID: 29146581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs in retinoblastoma.
    Yang M; Wei W
    Pathol Res Pract; 2019 Aug; 215(8):152435. PubMed ID: 31202519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
    Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
    Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
    Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
    Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance.
    Sui F; Ji M; Hou P
    Mol Cell Endocrinol; 2018 Jul; 469():11-22. PubMed ID: 28751134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
    Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
    Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.
    Lan X; Sun W; Dong W; Wang Z; Zhang T; He L; Zhang H
    Gene; 2018 Mar; 646():98-105. PubMed ID: 29287713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.